Found 8 matching trials
Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC
PHASE2The main purpose of the study is to evaluate safety and efficacy of taletre...
Status
Active Not Recruiting
Location
Beverly Hills Cancer Center
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
PHASE3The purpose of this phase 3 multicenter double-blind randomized study is to...
Study on the Effect of Famotidine on Pharmacokinetics of Taletrectinib
PHASE1This Phase 1 open-label trial aims to evaluate the effect of famotidine on ...
Location
Multiple Locations
Real-world Study of Taletrectinib for Advanced ROS1+ NSCLC With Brain Metastases
N/AThis is a multicenter, non-interventional, observational real-world study t...
Location
Zhejiang Cancer Hospital
Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)
PHASE2The purpose of this study is to evaluate the safety and tolerability of tal...
Location
Marone Cancer Center Cleveland Clinic Florida
Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression
N/AThis is a multicenter, non-interventional, observational real-world study t...
Location
Shanghai East Hospital (The East Hospital Affiliated to Tongji University)
A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients
PHASE3This is a Phase 3, randomized, open-label, comparative, multicenter, intern...
Location
The First Affiliated Hospital of Anhui Medical University
Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC
N/AThis Expanded Access Program will provide access of taletrectinib therapy t...
Status
No Longer Available
Location
Multiple Locations